arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Ascend Wellness Holdings, Inc.

AAWH
— Price unavailable
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
27 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
59
Health
Fair
Neutral
auto_awesome

Analytical Summary

Ascend Wellness Holdings, Inc. demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Profit Margin (%) which shows concerning trends. Consider comparing against peers in the Materials sector before making investment decisions.

Market Cap —
Dividend Yield —
Revenue Growth -0.9% ↗
Op. Margin 4.2% ↗
ROIC 1.3% ↘
FCF / Share $0.08 ↗
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity -3.89
info Valuation on last close.

27-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$126.12M
↓ -0.9% —
Net Income Profit after all expenses
$-29.49M
↓ -53.1% —
Operating Margin Operating profit as % of sales
4.2%
↑ +92.3% 22th
FCF / Share Free cash flow per share
$0.08
↑ +167.6% —
Long-Term Debt Long-term obligations
$334.36M
↑ +4.9% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
21
Returns
100
Financial Health ↓
74
Cash Quality
18

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 27 quarters